IXICO plc IXICO to Present at 10th Annual CNS Summit 2019
October 30 2019 - 5:00AM
RNS Non-Regulatory
TIDMIXI
IXICO plc
30 October 2019
30 October 2019
IXICO plc
("IXICO" or the "Company")
IXICO to Present at 10(th) Annual CNS Summit 2019
IXICO plc (AIM: IXI), the AI data analytics company delivering
insights in neuroscience, today announces that it is scheduled to
attend and present at the 10th Annual CNS Summit held from 31(st)
October to 3(rd) November 2019 in Boca Raton, Florida, USA.
10th Annual CNS Summit
31(st) October - 3(rd) November 2019, Boca Raton Resort,
Florida, USA
Robin Wolz, Senior Vice President of Science & Innovation at
IXICO will present a poster entitled "Automated sleep-wake
prediction from wearable sensors using neural networks - from data
collection to algorithm development, cross-validation and clinical
trial deployment" during the evening receptions on Friday 1(st) and
Saturday 2(nd) November 2019.
This study shows how AI technology improved the analysis of
sleep/wake accelerometry from wearables compared to traditional,
count-based measurements in a robust and reproducible way. Thus,
the exploratory use of this validated algorithm in clinical trials
is feasible and provides the collection of evidence needed to
support further development of real-world evidence in clinical
trial designs.
The rise in people using connected wearable devices has opened
the door for the medical field to harness real-time patient health
data to support clinical development of many diseases including
Alzheimer's and Parkinson's disease.
Founded by R&D leaders, the CNS Summit is a platform of
industry leaders working collaboratively to shape the future of the
life sciences with a focus on innovation and technology. The agenda
features top leaders from the regulators, pharmaceutical and
biotech companies, technology and services companies driving change
in the healthcare sector.
Poster authors:
Robin Wolz(1,2) , Luis Peraza(1) , Richard Joules(1) , Yves
Dauvilliers(3)
Affiliations: 1- IXICO, London, UK, 2- Imperial College London,
London, UK, 3- Department Neurology, Centre Hospitalier
Universitaire, Montpellier, France
For further information please contact:
IXICO plc +44 (0) 20 3763 7498
Giulio Cerroni, Chief Executive Officer
Optimum Strategic Communications +44 (0) 203 950 9144
Mary Clark / Supriya Mathur / Manel Mateus
IXICO@optimumcomms.com
About IXICO
IXICO's purpose is to advance medicine and human health by
turning data into clinically meaningful information, providing
valuable new insights in neuroscience and rare disease.
Our goal is to be a leading proponent in the use of AI in
clinical development, to improve biopharma R&D productivity
through the adoption of breakthrough data analytics in precision
healthcare. Through the deployment of novel AI algorithms, we
analyse and interpret brain scans and digital biosensor data to
enable better trial design, patient selection and ultimately
clinical outcomes across all phases of clinical evaluation. Our
data analytics services are deployed on some of the most important
clinical trials in neuroscience and rare disease, providing
valuable insights to disease progression and patient safety,
enabling our clients to make better informed decisions earlier in
the clinical development pathway.
More information is available on www.IXICO.com
About CNS Summit
CNS Summit is a platform for change and a community passionate
about shaping the future, with a focus on collaboration,
innovation, and technology. Its mission is to have a positive
impact on the success of clinical development programs. CNS Summit
believes this mission is its ethical duty to the patients they
serve by developing new treatments.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRABRBDGXXDBGCC
(END) Dow Jones Newswires
October 30, 2019 05:00 ET (09:00 GMT)
Ixico (LSE:IXI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ixico (LSE:IXI)
Historical Stock Chart
From Apr 2023 to Apr 2024
